Radiology-Pathology Correlations of Intracranial Clots: Current Theories, Clinical Applications, and Future Directions

References

1. 1.↵
   1. Gunning GM,
   2. McArdle K,
   3. Mirza M, et al

   . Clot friction variation with fibrin content: implications for resistance to thrombectomy. J Neurointerv Surg 2018;10:34–38 doi:10.1136/neurintsurg-2016-012721 pmid:28044009

   Abstract/FREE Full Text
2. 2.↵
   1. Choi MH,
   2. Park GH,
   3. Lee JS, et al

   . Erythrocyte fraction within retrieved thrombi contributes to thrombolytic response in acute ischemic stroke. Stroke 2018;49:652–59 doi:10.1161/STROKEAHA.117.019138 pmid:29374103

   Abstract/FREE Full Text
3. 3.↵
   1. Tomkins AJ,
   2. Schleicher N,
   3. Murtha L, et al

   . Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke. Exp Transl Stroke Med 2015;7:2 doi:10.1186/s13231-014-0014-y pmid:25657829

   CrossRefPubMed
4. 4.↵
   1. Shin JW,
   2. Jeong HS,
   3. Kwon H-J, et al

   . High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy. PLoS One 2018;13:e0197492 doi:10.1371/journal.pone.0197492 pmid:29782513

   CrossRefPubMed
5. 5.↵
   1. Patel TR,
   2. Fricano S,
   3. Waqas M, et al

   . Increased perviousness on CT for acute ischemic stroke is associated with fibrin/platelet-rich clots. AJNR Am J Neuroradiol 2021;42:57–64 doi:10.3174/ajnr.A6866 pmid:33243895

   Abstract/FREE Full Text
6. 6.↵
   1. Sporns PB,
   2. Hanning U,
   3. Schwindt W, et al

   . Ischemic stroke: histological thrombus composition and pre-interventional CT attenuation are associated with intervention time and rate of secondary embolism. Cerebrovasc Dis 2017;44:344–50 doi:10.1159/000481578 pmid:29130956

   CrossRefPubMed
7. 7.↵
   1. Weafer FM,
   2. Duffy S,
   3. Machado I, et al

   . Characterization of strut indentation during mechanical thrombectomy in acute ischemic stroke clot analogs. J Neurointerv Surg 2019;11:891–97 doi:10.1136/neurintsurg-2018-014601 pmid:30661030

   Abstract/FREE Full Text
8. 8.↵
   1. Fitzgerald S,
   2. Mereuta OM,
   3. Doyle KM, et al

   . Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome. J Neurosurg Sci 2019;63:292–300 doi:10.23736/S0390-5616.18.04629-5 pmid:30514073

   CrossRefPubMed
9. 9.↵
   1. Sporns PB,
   2. Jeibmann A,
   3. Minnerup J, et al

   . Histological clot composition is associated with preinterventional clot migration in acute stroke patients. Stroke 2019;50:2065–71 doi:10.1161/STROKEAHA.118.023314 pmid:31242825

   CrossRefPubMed
10. 10.↵
    1. Santos EM,
    2. Dankbaar JW,
    3. Treurniet KM, et al

    . Permeable thrombi are associated with higher intravenous recombinant tissue-type plasminogen activator treatment success in patients with acute ischemic stroke. Stroke 2016;47:2058–65 doi:10.1161/STROKEAHA.116.013306 pmid:27338928

    Abstract/FREE Full Text
11. 11.↵
    1. Boodt N,
    2. Compagne KC,
    3. Dutra BG, et al

    . Coinvestigators MR CLEAN Registry. Stroke etiology and thrombus computed tomography characteristics in patients with acute ischemic stroke: a MR CLEAN registry substudy. Stroke 2020;51:1727–35 doi:10.1161/STROKEAHA.119.027749 pmid:32404040

    CrossRefPubMed
12. 12.↵
    1. Santos EM,
    2. d’Esterre CD,
    3. Treurniet KM, et al

    . PRove-IT investigators. Added value of multiphase CTA imaging for thrombus perviousness assessment. Neuroradiology 2018;60:71–79 doi:10.1007/s00234-017-1907-y pmid:28963573

    CrossRefPubMed
13. 13.↵
    1. Chen Z,
    2. Shi F,
    3. Gong X, et al

    . Thrombus permeability on dynamic CTA predicts good outcome after reperfusion therapy. AJNR Am J Neuroradiol 2018;39:1854–59 doi:10.3174/ajnr.A5785 pmid:30166435

    Abstract/FREE Full Text
14. 14.↵
    1. Kim EY,
    2. Heo JH,
    3. Lee S-K, et al

    . Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 2006;67:1846–48 doi:10.1212/01.wnl.0000244492.99737.a8 pmid:17130421

    CrossRefPubMed
15. 15.↵
    1. Dutra BG,
    2. Tolhuisen ML,
    3. Alves HC, et al

    . MR CLEAN Registry Investigators. Thrombus imaging characteristics and outcomes in acute ischemic stroke patients undergoing endovascular treatment. Stroke 2019;50:2057–64 doi:10.1161/STROKEAHA.118.024247 pmid:31216961

    CrossRefPubMed
16. 16.↵
    1. Santos EM,
    2. Yoo AJ,
    3. Beenen LF, et al

    . MR CLEAN Investigators. Observer variability of absolute and relative thrombus density measurements in patients with acute ischemic stroke. Neuroradiology 2016;58:133–39 doi:10.1007/s00234-015-1607-4 pmid:26494462

    CrossRefPubMed
17. 17.↵
    1. Ho J,
    2. Nguyen D,
    3. Pirastefahr M, et al

    . Non-enhanced CT maximum intensity projections for the detection of large vessel occlusions. Austin J Cerebrovasc Dis Stroke 2017;4:1068 pmid:29367951

    PubMed
18. 18.↵
    1. Brinjikji W,
    2. Duffy S,
    3. Burrows A, et al

    . Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg 2017;9:529–34 doi:10.1136/neurintsurg-2016-012391 pmid:27166383

    Abstract/FREE Full Text
19. 19.↵
    1. Fitzgerald ST,
    2. Wang S,
    3. Dai D, et al

    . Platelet-rich clots as identified by Martius Scarlet Blue staining are isodense on NCCT. J Neurointerv Surg 2019;11:1145–49 doi:10.1136/neurintsurg-2018-014637 pmid:30952688

    Abstract/FREE Full Text
20. 20.↵
    1. Niesten JM,
    2. van der Schaaf IC,
    3. van Dam L, et al

    . Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation. PloS One 2014;9:e88882 doi:10.1371/journal.pone.0088882 pmid:24523944

    CrossRefPubMed
21. 21.↵
    1. Maekawa K,
    2. Shibata M,
    3. Nakajima H, et al

    . Erythrocyte-rich thrombus is associated with reduced number of maneuvers and procedure time in patients with acute ischemic stroke undergoing mechanical thrombectomy. Cerebrovasc Dis Extra 2018;8:39–49 doi:10.1159/000486042 pmid:29402828

    CrossRefPubMed
22. 22.↵
    1. Liebeskind DS,
    2. Sanossian N,
    3. Yong WH, et al

    . CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237–43 doi:10.1161/STROKEAHA.110.605576 pmid:21393591

    Abstract/FREE Full Text
23. 23.↵
    1. Berndt M,
    2. Friedrich B,
    3. Maegerlein C, et al

    . Thrombus permeability in admission computed tomographic imaging indicates stroke pathogenesis based on thrombus histology. Stroke 2018;49:2674–82 doi:10.1161/STROKEAHA.118.021873 pmid:30355200

    CrossRefPubMed
24. 24.↵
    1. Benson JC,
    2. Fitzgerald ST,
    3. Kadirvel R, et al

    . Clot permeability and histopathology: is a clot’s perviousness on CT imaging correlated with its histologic composition? J Neurointerv Surg 2020;12:38–42 doi:10.1136/neurintsurg-2019-014979 pmid:31239329

    Abstract/FREE Full Text
25. 25.↵
    1. Cines DB,
    2. Lebedeva T,
    3. Nagaswami C, et al

    . Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 2014;123:1596–1603 doi:10.1182/blood-2013-08-523860 pmid:24335500

    Abstract/FREE Full Text
26. 26.↵
    1. Payabvash S,
    2. Benson JC,
    3. Taleb S, et al

    . Susceptible vessel sign: identification of arterial occlusion and clinical implications in acute ischaemic stroke. Clin Radiol 2017;72:116–22 doi:10.1016/j.crad.2016.11.001 pmid:27889089

    CrossRefPubMed
27. 27.↵
    1. Kim SK,
    2. Yoon W,
    3. Kim TS, et al

    . Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 2015;36:1756–62 doi:10.3174/ajnr.A4402 pmid:26159515

    Abstract/FREE Full Text
28. 28.↵
    1. Schellinger PD,
    2. Chalela JA,
    3. Kang DW, et al

    . Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2005;26:618–24 pmid:15764589

    PubMedWeb of Science
29. 29.↵
    1. Puig J,
    2. Pedraza S,
    3. Demchuk A, et al

    . Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2012;33:90–96 doi:10.3174/ajnr.A2878 pmid:22158924

    Abstract/FREE Full Text
30. 30.↵
    1. Mokin M,
    2. Waqas M,
    3. Fifi J, et al

    . Clot perviousness is associated with first pass success of aspiration thrombectomy in the COMPASS trial. J Neurointerv Surg 2021;13:509–14 doi:10.1136/neurintsurg-2020-016434 pmid:32680875

    Abstract/FREE Full Text
31. 31.↵
    1. Mokin M,
    2. Morr S,
    3. Natarajan SK, et al

    . Thrombus density predicts successful recanalization with Solitaire stent retriever thrombectomy in acute ischemic stroke. J Neurointerv Surg 2015;7:104– 07 doi:10.1136/neurintsurg-2013-011017 pmid:24510378

    Abstract/FREE Full Text
32. 32.↵
    1. Froehler MT,
    2. Tateshima S,
    3. Duckwiler G, et al

    . UCLA Stroke Investigators. The hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke. J Neurointerv Surg 2013;5:289–93 doi:10.1136/neurintsurg-2012-010313 pmid:22619467

    Abstract/FREE Full Text
33. 33.↵
    1. Moftakhar P,
    2. English JD,
    3. Cooke DL, et al

    . Density of thrombus on admission CT predicts revascularization efficacy in large vessel occlusion acute ischemic stroke. Stroke 2013;44:243–45 doi:10.1161/STROKEAHA.112.674127 pmid:23111438

    Abstract/FREE Full Text
34. 34.↵
    1. Darcourt J,
    2. Withayasuk P,
    3. Vukasinovic I, et al

    . Predictive value of susceptibility vessel sign for arterial recanalization and clinical improvement in ischemic stroke. Stroke 2019;50:512–15 doi:10.1161/STROKEAHA.118.022912 pmid:30602358

    CrossRefPubMed
35. 35.↵
    1. Topcuoglu MA,
    2. Arsava EM,
    3. Kursun O, et al

    . The utility of middle cerebral artery clot density and burden assessment by noncontrast computed tomography in acute ischemic stroke patients treated with thrombolysis. J Stroke Cerebrovasc Dis 2014;23:e85–91 doi:10.1016/j.jstrokecerebrovasdis.2013.08.026 pmid:24119367

    CrossRefPubMed
36. 36.↵
    1. Mishra SM,
    2. Dykeman J,
    3. Sajobi TT, et al

    . Early reperfusion rates with IV tPA are determined by CTA clot characteristics. AJNR Am J Neuroradiol 2014;35:2265–72 doi:10.3174/ajnr.A4048 pmid:25059699

    Abstract/FREE Full Text
37. 37.↵
    1. Labiche LA,
    2. Malkoff M,
    3. Alexandrov AV

    . Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging 2003;13:28–33 pmid:12593128

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Alexandrov AV,
    2. Demchuk AM,
    3. Felberg RA, et al

    . High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000;31:610–14 doi:10.1161/01.STR.31.3.610 pmid:10700493

    Abstract/FREE Full Text
39. 39.↵
    1. Santos EM,
    2. Marquering HA,
    3. den Blanken MD, et al

    . MR CLEAN Investigators. Thrombus permeability is associated with improved functional outcome and recanalization in patients with ischemic stroke. Stroke 2016;47:732–41 doi:10.1161/STROKEAHA.115.011187 pmid:26846859

    Abstract/FREE Full Text
40. 40.↵
    1. Borst J,
    2. Berkhemer OA,
    3. Santos EM, et al

    . MR CLEAN Investigators, Value of thrombus CT characteristics in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2017;38:1758–64 doi:10.3174/ajnr.A5331 pmid:28751519

    Abstract/FREE Full Text
41. 41.↵
    1. Byun JS,
    2. Nicholson P,
    3. Hilditch CA, et al

    . Thrombus perviousness is not associated with first-pass revascularization using stent retrievers. Interv Neuroradiol 2019;25:285–90 doi:10.1177/1591019918825444 pmid:30714501

    CrossRefPubMed
42. 42.↵
    1. Bilgic AB,
    2. Gocmen R,
    3. Arsava EM, et al

    . The effect of clot volume and permeability on response to intravenous tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2020;29:104541 doi:10.1016/j.jstrokecerebrovasdis.2019.104541 pmid:31810719

    CrossRefPubMed
43. 43.↵
    1. Qiu W,
    2. Kuang H,
    3. Nair J, et al

    . Radiomics-based intracranial thrombus features on CT and CTA predict recanalization with intravenous alteplase in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2019;40:39–44 doi:10.3174/ajnr.A5918 pmid:30573458

    Abstract/FREE Full Text
44. 44.↵
    1. Hofmeister J,
    2. Bernava G,
    3. Rosi A, et al

    . Clot-based radiomics predict a mechanical thrombectomy strategy for successful recanalization in acute ischemic stroke. Stroke 2020;51:2488–94 doi:10.1161/STROKEAHA.120.030334 pmid:32684141

    CrossRefPubMed
45. 45.↵
    1. Velasco Gonzalez A,
    2. Buerke B,
    3. Görlich D, et al

    . Clot analog attenuation in non-contrast CT predicts histology: an experimental study using machine learning. Transl Stroke Res 2020;11:940–49 doi:10.1007/s1275-019-00766-z pmid:31933117

    CrossRefPubMed
46. 46.↵
    1. Chung JW,
    2. Kim YC,
    3. Cha J, et al

    . Characterization of clot composition in acute cerebral infarct using machine learning techniques. Ann Clin Transl Neurol 2019;6:739–47 doi:10.1002/acn3.751 pmid:31019998

    CrossRefPubMed
47. 47.↵
    1. Riedel CH,
    2. Jensen U,
    3. Rohr A, et al

    . Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced computed tomography reconstructions. Stroke 2010;41:1659–64 doi:10.1161/STROKEAHA.110.580662 pmid:20595670

    Abstract/FREE Full Text
48. 48.↵
    1. Miller TS,
    2. Brook AL,
    3. Riedel CH, et al

    . Expanding the role of NCCT in acute stroke imaging: thrombus length measurement and its potential impact on current practice. J Neurointerv Surg 2014;6:5–6 doi:10.1136/neurintsurg-2012-010531 pmid:23558864

    FREE Full Text
49. 49.↵
    1. De Meyer SF,
    2. Andersson T,
    3. Baxter B, et al

    . Clot Summit Group. Analyses of thrombi in acute ischemic stroke: a consensus statement on current knowledge and future directions. Int J Stroke 2017;12:606–14 doi:10.1177/1747493017709671 pmid:28534706

    CrossRefPubMed
50. 50.↵
    1. Mortimer AM,
    2. Little DH,
    3. Minhas KS, et al

    . Thrombus length estimation in acute ischemic stroke: a potential role for delayed contrast enhanced CT. J Neurointerv Surg 2014;6:244–48 doi:10.1136/neurintsurg-2013-010769 pmid:23703246

    Abstract/FREE Full Text
51. 51.↵
    1. Yoo J,
    2. Baek JH,
    3. Park H, et al

    . Thrombus volume as a predictor of nonrecanalization after intravenous thrombolysis in acute stroke. Stroke 2018;49:2108–15 doi:10.1161/STROKEAHA.118.021864 pmid:30354986

    CrossRefPubMed
52. 52.↵
    1. Linfante I,
    2. Llinas RH,
    3. Selim M, et al

    . Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002;33:2066–71 doi:10.1161/01.STR.0000021001.18101.A5 pmid:12154264

    Abstract/FREE Full Text
53. 53.↵
    1. Bhatia R,
    2. Hill MD,
    3. Shobha N, et al

    . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254–58 doi:10.1161/STROKEAHA.110.592535 pmid:20829513

    Abstract/FREE Full Text
54. 54.↵
    1. Seners P,
    2. Turc G,
    3. Maïer B, et al

    . Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta-analysis. Stroke 2016;47:2409–12 doi:10.1161/STROKEAHA.116.014181 pmid:27462117

    Abstract/FREE Full Text
55. 55.↵
    1. Tan IY,
    2. Demchuk AM,
    3. Hopyan J, et al

    . CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30:525–31 doi:10.3174/ajnr.A1408 pmid:19147716

    Abstract/FREE Full Text
56. 56.↵
    1. Derraz I,
    2. Bourcier R,
    3. Soudant M, et al

    . THRACE Investigators. Does clot burden score on baseline T2*-MRI impact clinical outcome in acute ischemic stroke treated with mechanical thrombectomy? J Stroke 2019;21:91–100 doi:10.5853/jos.2018.01921 pmid:30732444

    CrossRefPubMed
57. 57.↵
    1. Derraz I,
    2. Pou M,
    3. Labreuche J, et al

    . ASTER and the THRACE Trials Investigators. Clot burden score and collateral status and their impact on functional outcome in acute ischemic stroke. AJNR Am J Neuroradiol 2021;42:42–48 doi:10.3174/ajnr.A6865 pmid:33184069

    Abstract/FREE Full Text
58. 58.↵
    1. Li G,
    2. Wu G,
    3. Qin Z, et al

    . Prognostic value of clot burden score acute ischemic stroke after reperfusion therapies: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2019;28:104293 doi:10.1016/j.jstrokecerebrovasdis.2019.07.009 pmid:31383621

    CrossRefPubMed
59. 59.↵
    1. Martinod K,
    2. Wagner DD

    . Thrombosis: tangled up in NETs. Blood 2014;123:2768–76 doi:10.1182/blood-2013-10-463646 pmid:24366358

    Abstract/FREE Full Text
60. 60.↵
    1. Laridan E,
    2. Denorme F,
    3. Desender L, et al

    . Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol 2017;82:223–32 doi:10.1002/ana.24993 pmid:28696508

    CrossRefPubMed
61. 61.↵
    1. Fuchs TA,
    2. Brill A,
    3. Duerschmied D, et al

    . Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010;107:15880–85 doi:10.1073/pnas.1005743107 pmid:20798043

    Abstract/FREE Full Text
62. 62.↵
    1. Ducroux C,
    2. Di Meglio L,
    3. Loyau S, et al

    . Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke. Stroke 2018;49:754–57 doi:10.1161/STROKEAHA.117.019896 pmid:29438080

    Abstract/FREE Full Text
63. 63.↵
    1. Staessens S,
    2. Denorme F,
    3. Francois O, et al

    . Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica 2020;105:498–507 doi:10.3324/haematol.2019.219881 pmid:31048352

    Abstract/FREE Full Text
64. 64.↵
    1. Douglas A,
    2. Fitzgerald S,
    3. Mereuta OM, et al

    . Platelet-rich emboli are associated with von Willebrand factor levels and have poorer revascularization outcomes. J Neurointerv Surg 2020;12:557–62 doi:10.1136/neurintsurg-2019-015410 pmid:31685695

    Abstract/FREE Full Text
65. 65.↵
    1. Bongers TN,
    2. de Maat MP,
    3. van Goor ML, et al

    . High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 2006;37:2672–77 doi:10.1161/01.STR.0000244767.39962.f7 pmid:16990571

    Abstract/FREE Full Text